Practice Point® CME Podcasts: Expert Discussions in Pulmonology™

Practice Point® CME Podcasts: Expert Discussions in Pulmonology™
Podcast Description
Welcome to our pulmonology podcasts, covering the latest research and expert insights on all things related to pulmonary health. Hosted by leading experts, these podcasts explore a wide range of topics, including PH, PAH, PH-ILD, COPD, lung cancer, and the latest updates from pulmonary conferences. Each episode features insights from healthcare professionals, cutting-edge studies, and clinical case scenarios to improve knowledge for diagnosis and treatment. Whether you're a healthcare professional seeking credit, or someone passionate about lung health, our podcasts offer valuable information to improve the understanding and care of the pulmonary system.
Podcast Insights
Content Themes
The podcasts cover a broad spectrum of content related to pulmonary health, including pulmonary hypertension (PH), pulmonary arterial hypertension (PAH), interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD), and lung cancer, featuring episodes that analyze updates from prominent pulmonary conferences, explore clinical case studies, and review new treatment algorithms.

Welcome to our pulmonology podcasts, covering the latest research and expert insights on all things related to pulmonary health. Hosted by leading experts, these podcasts explore a wide range of topics, including PH, PAH, PH-ILD, COPD, lung cancer, and the latest updates from pulmonary conferences. Each episode features insights from healthcare professionals, cutting-edge studies, and clinical case scenarios to improve knowledge for diagnosis and treatment. Whether you’re a healthcare professional seeking credit, or someone passionate about lung health, our podcasts offer valuable information to improve the understanding and care of the pulmonary system.

Despite significant advancements in the management of pulmonary hypertension (PH), several unmet needs remain. Patients continue to face challenges related to symptom control, mental health, and the long-term impacts of both the disease and its treatments. Additionally, there is a critical need for improved global access to care, multidimensional support, and advocacy. In this podcast episode, Dr. Jean Elwing and Dr. Oksana Shlobin discuss these gaps by focusing on the latest updates from the 7th World Symposium on Pulmonary Hypertension (WSPH), offering insights into the latest clinical classifications, risk stratifications, and treatment strategies.
This podcast aims to enhance clinical practice by presenting key research findings, new treatment algorithms, and the implications of emerging therapies. The discussion will include advances in multimodality imaging, genetics, and right ventricular function, highlighting how these innovations improve PH diagnosis and patient management. Through an expert-led presentation and interactive Q&A session, participants will gain a comprehensive understanding of how these developments will shape future research and personalized care for PH patients.
Launch Date: November 19, 2024
Release Date: November 19, 2024
Expiration Date: October 31, 2025
FACULTY
Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati
Oksana Shlobin, MD
Medical Director, Pulmonary Hypertension Program
Director of Education and Outreach, Advanced Lung Disease Program
Inova Fairfax Hospital
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.